Saliva α-synuclein and a high extinction coefficient protein: A novel approach in assessment biomarkers of Parkinson′s disease
Open Access
- 1 January 2014
- journal article
- research article
- Published by Medknow in North American Journal of Medical Sciences
- Vol. 6 (12) , 633-637
Abstract
Background: The pathological hallmark of Parkinson's disease (PD) is the appearance of intracytoplasmic inclusions known as Lewy bodies in which its principal component is α-synuclein. Aim: This study aimed to determine salivary α-synuclein and the extinction coefficient of the saliva protein as biomarkers of PD. Materials and Methods: This observational study was done in Department of Pharmacology, College of Medicine in cooperation with Department of Oral Medicine, College of Dentistry at Al-Mustansiriya University in Baghdad, Iraq from September 2013 to March 2014. A total number of 20 PD patients and 20 healthy subjects were enrolled in the study. Unstimulated saliva obtained from each participant obtained for determination of salivary flow rate, saliva protein and α-synuclein using enzyme linked immune sorbent assay (ELISA) technique. Results: Total saliva protein and uncontaminated protein with nucleic acids are significantly higher in PD compared with healthy subjects. The mean extinction coefficient of that protein is 27.25 M.cm -1 which significantly (P < 0.001) less than corresponding value of healthy subjects (33.48 M.cm−1 ). Saliva α-synuclein level is significantly less in PD (65 ± 52.2 pg/ml) than healthy subjects (314.01 ± 435.9 pg/ml). Conclusions: We conclude that saliva α-synuclein serves as a biomarker for PD if its level compared with healthy subjects, and a specific protein with extinction coefficient 27.25 M.cm-1 is detected in saliva of Parkinson's patients.Keywords
This publication has 22 references indexed in Scilit:
- Parkinson's Disease: From Genetics to Clinical PracticeCurrent Genomics, 2014
- Neuropathology of cigarette smokingActa Neuropathologica, 2013
- Relationship between oral health and its impact on the quality life of Alzheimer's disease patients: a supportive care trial.2013
- Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptomsJournal of Neurology, 2012
- Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's diseaseBrain, 2011
- Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s diseaseActa Neuropathologica, 2010
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders, 2008
- Elevated α-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's diseaseNucleic Acids Research, 2008
- Mild Parkinsonian signs: An overview of an emerging conceptMovement Disorders, 2007
- [6] Quantitation of protein1990